Endocrine Gland Neoplasms  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

53 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00004190: Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer

Completed
2
59
US, Canada
gemcitabine hydrochloride, oxaliplatin
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Pancreatic Cancer
04/03
06/03
NCT00005836: Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy

Completed
2
US, Canada
oxaliplatin
Gynecologic Oncology Group, National Cancer Institute (NCI)
Ovarian Cancer, Primary Peritoneal Cavity Cancer
 
07/04
NCT00091182: Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Completed
2
180
US
oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP
National Cancer Institute (NCI)
Childhood Central Nervous System Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor, Childhood Hepatoblastoma, Childhood Hepatocellular Carcinoma, Childhood High-grade Cerebral Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Childhood Malignant Ovarian Germ Cell Tumor, Childhood Malignant Testicular Germ Cell Tumor, Childhood Teratoma, Recurrent Adrenocortical Carcinoma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Malignant Germ Cell Tumor, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Colon Cancer, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Nasopharyngeal Cancer, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Rectal Cancer, Recurrent Renal Cell Cancer
02/06
 
NCT00112528: Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Completed
2
53
US
bevacizumab, gemcitabine hydrochloride, oxaliplatin
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Pancreatic Cancer
08/06
11/10
NCT00096070: Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer

Completed
2
50
US
radiation therapy, irradiation, radiotherapy, therapy, radiation, oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, fluorouracil, 5-fluorouracil, 5-Fluracil, 5-FU, gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar
National Cancer Institute (NCI)
Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer
04/07
 
NCT00786006: Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer

Completed
2
61
RoW
FOLFIRI.3, FOLFOX
Asan Medical Center
Metastatic Pancreatic Cancer
03/09
09/09
NCT00425841: Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer

Completed
2
29
Europe
gemcitabine hydrochloride, oxaliplatin, adjuvant therapy, neoadjuvant therapy, hypofractionated radiation therapy, stereotactic radiosurgery
Technische Universität München
Pancreatic Cancer
 
12/09
NCT00761241: Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT

Completed
2
40
US
Gemcitabine, Docetaxel, 5FU, Oxaliplatin, Alpha-interferon, Abdominal/pelvic radiation therapy, Pancreaticoduodenectomy
Benaroya Research Institute, Sanofi
Pancreatic Cancer
03/10
04/10
NCT00564720: Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer

Terminated
2
140
Europe
Gemcitabine, Gemzar, Erlotinib, Tarceva, Oxaliplatin, Eloxatin
Hellenic Oncology Research Group, University Hospital of Crete
Pancreatic Cancer
03/11
03/11
NCT00313612: Oxaliplatin and Topotecan in Advance Ovarian Cancer

Terminated
2
39
US
oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, topotecan, hycamptamine, Hycamtin, SKF S-104864-A, TOPO
National Cancer Institute (NCI)
Recurrent Ovarian Epithelial Cancer
05/11
12/12
NCT00338039: Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients

Completed
2
69
US
Cetuximab, C225, Erbitux, IMC-C225, Gemcitabine, Gemzar, Gemcitabine Hydrochloride, Oxaliplatin, Eloxatin, Capecitabine, Xeloda, Radiotherapy, XRT
M.D. Anderson Cancer Center, Bristol-Myers Squibb
Pancreatic Cancer
06/11
06/11
NCT01588964: IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer

Completed
2
30
Europe
HIPEC, IPHC, Hypertermic intraperitoneal chemotherapy
Catholic University of the Sacred Heart
Ovarian Epithelial Cancer Recurrent
10/11
12/11
NCT01454180 / 2011-001017-13: Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets

Completed
2
31
Europe
gemcitabine, or gemcitabine and capecitabine, or gemcitabine and erlotinib, or FOLFIRINOX, or FOLFOX, or FOLFIRI., Gemcitabine, Gemcitabine-Capecitabine, Gemcitabine-Erlotinib, FOLFOXIRI, FOLFOX, FOLFIRI
Centro Nacional de Investigaciones Oncologicas CARLOS III, Hospital Universitario de Fuenlabrada, Apices Soluciones S.L., Grupo Hospital de Madrid
Advanced Pancreatic Carcinoma
10/11
12/14
NCT00585078: Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma

Completed
2
40
US
Capecitabine, Xeloda, Oxaliplatin, Eloxatin
Beth Israel Deaconess Medical Center, Sanofi
Pancreatic Cancer
12/11
12/11
NCT00456599: Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer

Completed
2
71
US, Canada
gemcitabine, Gemzar, oxaliplatin, Eloxatin, Radiation, RT
University of Michigan Rogel Cancer Center, Sanofi, Johns Hopkins University, Princess Margaret Hospital, Canada, Ohio State University
Pancreatic Cancer
05/12
01/13
GEMOX-T, NCT00636883: Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer

Terminated
2
9
RoW
Gemcitabine, Oxaliplatin, Erlotinib
National Guard Health Affairs
Pancreatic Cancer
07/12
07/12
NCT01473303: Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer

Withdrawn
2
0
US
ganitumab, fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin, placebo, questionnaire administration
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Pancreatic Cancer
08/12
 
NCT00536874: Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Completed
2
39
US
gemcitabine hydrochloride, oxaliplatin, protein expression analysis, proteomic profiling, diagnostic laboratory biomarker analysis, adjuvant therapy, neoadjuvant therapy, therapeutic conventional surgery
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Pancreatic Cancer
09/12
02/17
NCT01017809: Prolonged Emend in a Study (NYU 03-67) of Oxaliplatin and Topotecan in Previously Treated Ovarian Cancer

Withdrawn
2
0
US
Aprepitant, Emend
NYU Langone Health
Ovarian Cancer
12/12
12/13
NCT01531712 / 2010-021872-27: Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable

Terminated
2
6
Europe
Gemcitabine, gemzar, Radiotherapy, Tarceva, Erlotinib, Oxaliplatin, ELOXATIN
Institut Català d'Oncologia
Pancreatic Cancer
12/12
12/12
NCT00408564: Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Completed
2
39
US
cetuximab, capecitabine, oxaliplatin, conventional surgery, radiation therapy, Gemcitabine
Medical University of South Carolina
Pancreatic Cancer
04/13
04/13
NCT01359007: FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

Terminated
2
5
US
Irinotecan, Oxaliplatin, Leucovorin, 5-FU
University of Oklahoma
Adenocarcinoma of Pancreas
10/13
10/13
NCT01505413: Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
33
RoW
Erlotinib, tarceva, Gemcitabine, gemza, gemcibine, Oxaliplatin, oxalitin
Soonchunhyang University Hospital
Pancreatic Cancer
12/13
03/14
NCT01481701: A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

Completed
2
90
Europe
Oxaliplatin, No other intervention, oxaliplatin
Jules Bordet Institute
Ovarian Carcinoma, Relapse
05/14
05/14
NCT00957905: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

Completed
2
36
US
Alvocidib Hydrochloride, 4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5, 7-dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-, hydrochloride, (-)-cis-, Flavopiridol Hydrochloride, HL-275, HMR 1275, L-86-8275, L-868275, MDL 107,826A, MDL-107826A, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Actino-Hermal, Adrucil, Arumel, Cytosafe, Efudex, Efurix, Fiverocil, Fluoro Uracil, Fluoroplex, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Flurox, Ribofluor, Ro 2-9757, Ro-2-9757, Timazin, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Oxaliplatin, 1-OHP, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669
National Cancer Institute (NCI)
Recurrent Extragonadal Seminoma, Recurrent Malignant Extragonadal Germ Cell Tumor, Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor, Stage III Testicular Cancer, Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor, Stage IV Extragonadal Seminoma, Stage IV Ovarian Germ Cell Tumor
08/14
08/14
NCT00609336: Perioperative Therapy for Resectable Pancreatic Cancer

Completed
2
35
US
gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, docetaxel, RP 56976, Taxotere, TXT, capecitabine, CAPE, Ro 09-1978/000, Xeloda, intensity-modulated radiation therapy, IMRT, oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, pancreatic surgical procedure, pancreatic surgery, therapeutic conventional surgery, laboratory biomarker analysis
University of Washington, National Cancer Institute (NCI)
Adenocarcinoma of the Pancreas, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer
11/14
12/16
NCT01523457: Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer

Completed
2
75
US
Folfirinox
Yale University
Metastatic Pancreatic Cancer, Pancreatic Cancer
12/14
12/15
FLAP, NCT02351219: FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer

Completed
2
50
Europe
FOLFOXIRI
Azienda Ospedaliero, Universitaria Pisana
Pancreatic Carcinoma Stage III
12/14
12/14
NCT00871169: Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer

Completed
2
61
US
Irinotecan, oxaliplatin, and cetuximab, Eloxatin, ERBITUX
New Mexico Cancer Care Alliance
Pancreatic Cancer
04/15
04/15
SWOG-S1115, NCT01658943: Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Completed
2
137
US
Akt Inhibitor MK2206, MK2206, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Actino-Hermal, Adrucil, Arumel, Cytosafe, Efudex, Efurix, Fiverocil, Fluoro Uracil, Fluoroplex, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Flurox, Ribofluor, Ro 2-9757, Ro-2-9757, Timazin, Oxaliplatin, 1-OHP, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Selumetinib, ARRY-142886, AZD6244, MEK Inhibitor AZD6244
National Cancer Institute (NCI)
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer
06/15
06/15
NCT01488552: Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

Completed
2
60
US
Gemcitabine, Gemzar, nab-paclitaxel, Abraxane, FOLFIRINOX, 5-FU, Eloxitan, Campostar, Immunohistochemistry (IHC) Analysis, Metformin, Glucophage, mFOLFIRI
Pancreatic Cancer Research Team
Stage IV Pancreatic Cancer
08/15
08/16
NCT01936974: (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma

Terminated
2
7
US
Gemcitabine, Gemzar, Bevacizumab, Avastin, Carboplatin, Paraplatin, Cisplatin, Platinol, Oxaliplatin, Eloxatin
Western Regional Medical Center
Ovarian Carcinoma, Fallopian Tube Carcinoma, Peritoneal Carcinoma
08/15
08/15
NCT00183820: Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

Completed
2
30
US
paclitaxel, gemcitabine, and oxaliplatin
University of Southern California, Sanofi
Testicular Cancer, Germ Cell Neoplasm
12/15
08/16
NCT01581307: Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets

Completed
2
9
US
FOLFOX7 (Folinic acid, 5-Fluorouracil, and Oxaliplatin), Leucovorin, LV, FOL, OX, 5-Fluorouracil (5-FU), FOLFOX, ELOXATIN, TheraSpheres, radiotherapy, radioembolization
H. Lee Moffitt Cancer Center and Research Institute, BTG International Inc.
Liver Cancer, Pancreatic Cancer
02/16
03/16
NCT02345460: Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study

Terminated
2
1
US
Irinotecan Hydrochloride, Oxaliplatin, Leucovorin Calcium, CF, Fluorouracil, Laboratory Biomarker Analysis
Case Comprehensive Cancer Center, National Cancer Institute (NCI)
Pancreatic Adenocarcinoma, Poorly Differentiated Malignant Neoplasm, Resectable Pancreatic Cancer, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer, Undifferentiated Pancreatic Carcinoma
02/16
03/16
NCT01888978: Molecularly Tailored Therapy for Pancreas Cancer

Completed
2
19
US
Gem-OX, Gemcitabine, Gemzar, Oxaliplatin, Eloxatin, Gem-5FU, 5-FU, 5-fluorouracil, Gem-Tax, Docetael, taxotere, Modified FOLFOX-6, 5-Fluorourcil, Leucovorin, Ox-Tax, Docetaxel, Taxotere, Oxalipaltin, FOLFIRI, Irinotecan, CPT-11, 5-Fluorouracil, Tax-Iri
Georgetown University
Pancreatic Cancer
06/16
01/18
NCT02243007: Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer

Terminated
2
7
US
FOLFIRINOX, Gemcitabine/nab-Paclitaxel, Radiation therapy, Capecitabine, Xeloda
Massachusetts General Hospital
Resectable Pancreatic Cancer, Pancreatic Ductal Carcinoma
06/16
06/16
NCT02984501: Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer

Completed
2
41
Europe
Radiation, Neoadjuvant therapy, Chemotherapy, Induction therapy
Campus Bio-Medico University
Pancreatic Cancer
08/16
08/16
NCT01688336: FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer

Terminated
2
9
US
FOLFIRINOX, FOLFIRINOX is a chemotherapy regimen comprised of the following drugs, given in combination, -Oxaliplatin, -Leucovorin, -Irinotecan, -5FU
UNC Lineberger Comprehensive Cancer Center
Pancreatic Cancer
08/16
11/16
NCT02035072 / 2010-020379-22: Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.

Completed
2
40
Europe
Gemcitabine, Oxaliplatin, oxalipaltin, Hypofractionated RT
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Unresectable Pancreatic Cancer, Nonmetastatic Pancreatic Cancer, Locally Advanced Pancreatic Cancer
12/16
12/16
NCT02195180 / 2013-004262-34: Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

Completed
2
141
Europe
ERY001, L asparaginase encapsulated in erythrocytes, Gemcitabine, 5-fluoro-uracil/oxaliplatin/leucovorin (folfox)
ERYtech Pharma
Pancreatic Adenocarcinoma Metastatic
02/17
11/17
NCT02241551: Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer

Terminated
2
2
US
gemcitabine/nab-paclitaxel, Gemzar, ABRAXANE, mFOLFIRINOX, irinotecan, fluorouracil, oxaliplatin
Nathan Bahary, MD
Borderline Resectable Pancreatic Cancer
03/17
03/17
NCT02558868: Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic Cancer

Completed
2
80
RoW
Irinotecan, Oxaliplatin
Zhejiang University
Pancreatic Neoplasms
09/17
12/17
THYGEMOX, NCT02472080: Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study

Terminated
2
21
Europe
gemcitabine -oxaliplatine combination
Assistance Publique - Hôpitaux de Paris
Thyroid Cancer
04/18
01/19
NCT00242190: Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer

Completed
1/2
40
US
oxaliplatin, gemcitabine, radiation therapy
University of Michigan Rogel Cancer Center, Sanofi-Synthelabo
Pancreatic Neoplasms
03/06
02/10
CORGI, NCT01016639: Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer

Completed
1/2
106
Europe
oxaliplatin, capecitabine, radiotherapy
Lund University Hospital, Roche Pharma AG, Sanofi-Synthelabo
Stomach Cancer, Gall Bladder Cancer, Bile Ductus Cancer, Pancreas Cancer, Colorectal Cancer
07/07
07/09
NCT00307723: Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer

Terminated
1/2
52
US
bevacizumab, 5-Fluorouracil, Oxaliplatin, gemcitabine, External Beam Radiation Therapy
Massachusetts General Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Genentech, Inc., Sanofi
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
08/07
07/09
GEMOXEL, NCT00744640: Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma

Checkmark Data ASCO
Jun 2012 - Jun 2012: Data ASCO
Checkmark Data
Jan 2012 - Jan 2012: Data
Completed
1/2
46
Europe
gemcitabine, oxaliplatin, capecitabine
University Hospital, Basel, Switzerland, Swiss National Science Foundation, Swiss Cancer League, Roche Pharma AG, Sanofi
Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer
02/09
12/09
NCT00463840: Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer

Terminated
1/2
24
US
Oxaliplatin, Oxaliplatin: Eloxatin, 5FU, 5-Fluorouracil, Radiation, Surgery, FOLFOX 6
NYU Langone Health, Sanofi
Pancreatic Cancer
07/10
10/15
NCT01042028: A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Checkmark ASCO-GI 2014
Jan 2014 - Jan 2014: ASCO-GI 2014
Terminated
1/2
39
Europe
Everolimus, Cetuximab, Irinotecan, RAD001, Capecitabine, Oxaliplatine, Xeloda, Eloxatin
Per Pfeiffer, Odense University Hospital, Aarhus University Hospital
Pancreatic Cancer
11/12
01/14
NCT01632306: A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

Terminated
1/2
13
US
LY2090314, FOLFOX, FOLFOX (leucovorin + 5-fluorouracil + oxaliplatin), Gemcitabine, Gemzar, LY188011, Nab-paclitaxel
Eli Lilly and Company, Mayo Clinic
Pancreatic Cancer
06/15
06/15
NabucCO, NCT02109341: Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer

Completed
1/2
148
Europe
Paclitaxel bound albumine, nab-paclitaxel
Gruppo Oncologico Italiano di Ricerca Clinica
Metastatic Pancreatic Cancer
12/15
01/16
NCT02575508: Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Withdrawn
1/2
0
US
Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Actino-Hermal, Adrucil, Arumel, Cytosafe, Efudex, Efurix, Fiverocil, Fluoro Uracil, Fluoroplex, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Flurox, Ribofluor, Ro 2-9757, Ro-2-9757, Timazin, Irinotecan Hydrochloride, Campto, Camptosar, Camptothecin 11, Camptothecin-11, CPT 11, CPT-11, U-101440E, Laboratory Biomarker Analysis, Oxaliplatin, 1-OHP, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, pan FGFR Kinase Inhibitor BGJ398, BGJ398, Pharmacological Study
Roswell Park Cancer Institute, National Cancer Institute (NCI)
Colon Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Rectal Adenocarcinoma, Stage III Pancreatic Cancer, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer, Stage IV Pancreatic Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
05/20
 

Download Options